Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119374) titled 'Letermovir for the Prevention of Cytomegalovirus Infection Following Intensive Immunosuppressive Therapy' on Feb. 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
aplastic anemia
Intervention:
Treatment Group:Letermovir
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-01
Target Sample Size: Treatment Group:55;Control Group:55;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310060
Published ...